On the other hand, there was no significant effect in the number/tubule and expression levels of SALL4 and PLZF in (AML + CYT)-treated mice compared to the AML- or CYT-treated group, although it was significant compared to CT (Figure 5A,A1,B,B1, respectively). This evidence concerns the gene SALL4 and acute myeloid leukemia.